Newsroom
The latest from KolateAI.
Company milestones, media appearances, award wins, and perspectives on AI-driven drug development, straight from the team.
2026
Jun 2026
Award
KolateAI Graduates PharmStars Spring 2026 Cohort
LinkedIn
↗
May 20, 2026
Event
KolateAI Presents Metabolic Syndrome & Klotho Modulation Research at ISPOR 2026
LinkedIn
↗
Apr 2026
Event
KolateAI Joins AI in Precision Medicine Panel at Princeton Tech Meetup
LinkedIn
↗
Feb 6, 2026
Insight
KolateAI Advances Clinical Trials with AI-Driven Insights
LinkedIn
↗
Jan 11, 2026
Insight
Where Health Meets Strategy: Innovative Models of Care
LinkedIn
↗
2025
Dec 17, 2025
Insight
Evidence as Advantage: Cutting Trial Costs & Boosting Drug ROI
LinkedIn
↗
Oct 8, 2025
Feature
KolateAI on Meet the Drapers: The Real Pitch Experience
LinkedIn
↗
May 1, 2025
Award
KolateAI Recognized as TiE50 Top Startup Award Winner
LinkedIn
↗
Apr 26, 2025
Podcast
Lab to Lounge: Exploring Biopharma's Inner Workings
LinkedIn
↗
Mar 18, 2025
Podcast
AI in Clinical Trials and Healthcare R&D: Founder Series, Episode 4
LinkedIn
↗
Feb 26, 2025
Podcast
MedBricks Webcast
LinkedIn
↗
Jan 27, 2025
Event
IIT Startups Demo Day
LinkedIn
↗
Jan 23, 2025
Event
AI in Life Sciences: Panel Discussion
LinkedIn
↗
Jan 14, 2025
Event
Fierce Pharma JPM Week
LinkedIn
↗
2024
Dec 8, 2024
Event
ASH 2024 Conference
LinkedIn
↗
Nov 20, 2024
Award
Celebrating Innovation: KolateAI Wins "Most Innovative Solution" Award
LinkedIn
↗
Oct 24, 2024
Insight
Breaking the 90% Failure Cycle in Clinical Development
LinkedIn
↗
Oct 21, 2024
Milestone
Welcoming Cohort VII: Pioneering the Future of Healthcare
LinkedIn
↗
Oct 18, 2024
Award
Meet the Top 5 Finalists of the TiE New York + IIT Bombay Pitch Competition
LinkedIn
↗
Aug 12, 2024
Milestone
KolateAI PharmaTech Inc. Lights Up Times Square
LinkedIn
↗
Jan 8, 2024
Milestone
KolateAI Joins ERA NYC's Winter 2024 Accelerator Cohort
ERA NYC
↗
Stay in the Loop
Follow along, or get in touch directly.
Company updates and media appearances are posted first on LinkedIn, or reach out for press inquiries.